Oral Administration of Egg- and Soy-Derived Lysophosphatidylcholine Mitigated Acetylcholine Depletion in the Brain of Scopolamine-Treated Rats
Nutrients · 2023
DOI: 10.3390/nu15163618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Ryohei Tanaka-Kanegae und 2 weiteren Autor:innen. Beteiligte Einrichtung: Saga Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd. 5006-5 Aza Higashiyama, Yoshinogari-cho, Kanzaki-gun, Omagari, Saga 842-0195,…. Hauptthemen laut MEDLINE: Acetylcholine, Lecithins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Otsuka Pharmaceutical Co., Ltd.
Abstract (Originalsprache)
Enzyme-modified lecithin that contains lysophosphatidylcholine (LPC) is generally recognized as safe. However, its potential as a functional ingredient has been less investigated than other choline (Ch)-containing compounds, such as glycerophosphocholine (GPC). Reports on the possibility of LPC functioning as a cholinergic precursor in vivo and on its kinetics are limited to docosahexaenoic acid-bound LPC. Herein, three experiments were performed to investigate these processes in scopolamine (SCO)-treated rats. First, an egg-derived LPC reagent was orally administered to rats, and brain acetylcholine (ACh), Ch, plasma Ch, and LPC were measured. Second, soy- and rapeseed-derived enzyme-modified lecithins and GPC were administered for comparison. Third, soy-derived enzyme-modified lecithins with different fat contents were administered for comparison. The LPC reagent mitigated SCO-induced ACh depletion at 500 mg/kg body weight and increased plasma Ch, but not LPC, concentrations. Additionally, soy-derived LPC-containing food additive counteracted brain ACh depletion similarly to GPC. Interestingly, plasma Ch and linoleoyl-LPC levels were higher when soy-derived LPC with a higher fat content was administered, whereas the plasma levels of palmitoyl-LPC decreased and those of total LPC remained constant. In conclusion, egg- and soy-derived LPC species function as cholinergic precursors in vivo, and future studies should explore this potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Saga Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd. 5006-5 Aza Higashiyama, Yoshinogari-cho, Kanzaki-gun, Omagari, Saga 842-0195, Japan.
ORCID-Profile: Ryohei Tanaka-Kanegae
Förderung
- Otsuka Pharmaceutical Co., Ltd
Zitieren
APA
Tanaka-Kanegae, R., Kimura, H., & Hamada, K. (2023). Oral Administration of Egg- and Soy-Derived Lysophosphatidylcholine Mitigated Acetylcholine Depletion in the Brain of Scopolamine-Treated Rats. Nutrients. https://doi.org/10.3390/nu15163618
Vancouver
Tanaka-Kanegae R, Kimura H, Hamada K. Oral Administration of Egg- and Soy-Derived Lysophosphatidylcholine Mitigated Acetylcholine Depletion in the Brain of Scopolamine-Treated Rats. Nutrients. 2023. doi:10.3390/nu15163618
BibTeX
@article{TanakaKanegae2023,
author = {Tanaka-Kanegae, Ryohei and Kimura, Hiroyuki and Hamada, Koichiro},
title = {Oral Administration of Egg- and Soy-Derived Lysophosphatidylcholine Mitigated Acetylcholine Depletion in the Brain of Scopolamine-Treated Rats},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15163618}
}
EUVIMED